Pay in 4 interest-free payments of $6.31 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Providers must include a clear statement of the patients diagnosis (e.g., primary immunodeficiency disorders [ICD-10 D80-D84], chronic inflammatory demyelinating polyneuropathy [ICD-10 G61.81]) and evidence of medical necessity
Due to this, different routes for the administration of supplements may be necessary, such as: Oral replacement therapy is recommended to patients with asymptomatic, moderate illness who have no concerns about absorption or compliance
Oral B12 cannot get into the bloodstream in normal doses
We cannot take responsibility for incorrect shipping details
November 5, 2019
US$ 25.51
US$ 27.15
US$ 20.77
US$ 25.05
US$ 25.46
US$ 27.77
